U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203991
Company: LUPIN LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription AT No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/20/2015 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/02/2022 SUPPL-14 Labeling-Package Insert

Label is not available on this site.

11/02/2022 SUPPL-11 Labeling-Package Insert

Label is not available on this site.

11/24/2020 SUPPL-9 Labeling-Container/Carton Labels

Label is not available on this site.

11/02/2022 SUPPL-6 Labeling-Package Insert

Label is not available on this site.

BIMATOPROST

SOLUTION/DROPS;OPHTHALMIC; 0.03%
TE Code = AT

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 210263 ALEMBIC
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 090449 APOTEX
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 205537 EUGIA PHARMA
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 210126 GLAND PHARMA LTD
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 203991 LUPIN LTD
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 202505 MICRO LABS
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 202565 SANDOZ
BIMATOPROST BIMATOPROST 0.03% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 207601 SOMERSET THERAPS LLC
Back to Top